Cadrenal Therapeutics, INC. (CVKD) — DEF 14A Filings
All DEF 14A filings from Cadrenal Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Cadrenal Sets Sept. 24 Annual Meeting, Seeks Director Election, Auditor Ratification
— Jul 31, 2025 Risk: low
Cadrenal Therapeutics, Inc. (CVKD) filed a Definitive Proxy Statement (DEF 14A) on July 31, 2025, for its Annual Meeting of Stockholders scheduled for September -
Cadrenal Therapeutics Files Definitive Proxy Statement
— Jun 11, 2024 Risk: low
Cadrenal Therapeutics, Inc. filed its definitive proxy statement on June 11, 2024, for its annual meeting on July 29, 2024. The company, located at 822 A1A Nort
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX